Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer
NCT Number:
NCT04620239
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Bladder
Study Objectives:
This is a phase 3, open label, single arm study of TOOKAD in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade upper tract urothelial carcinoma in either the kidney or the ureter. The patients will be treated with TOOKAD (padeliporfin) VTP in two phases: an Induction Treatment Phase and a Maintenance Treatment Phase.
Study Documents
(MUSC NetID required for document access)